These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34344008)

  • 21. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
    Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
    AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
    [No Abstract]   [Full Text] [Related]  

  • 22. Ultraselective conventional transarterial chemoembolization: When and how?
    Miyayama S
    Clin Mol Hepatol; 2019 Dec; 25(4):344-353. PubMed ID: 31022779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
    Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
    Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter arterial chemoembolization with anticancer drug in iodized oil for primary hepatic carcinoma.
    Guo JY; Yen D; Huang ZZ; Hu GD; Liu PC
    Cardiovasc Intervent Radiol; 1989; 12(4):181-7. PubMed ID: 2557153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
    Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres.
    Seki A; Hori S; Shimono C
    Jpn J Radiol; 2015 Dec; 33(12):741-8. PubMed ID: 26493810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
    Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
    J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study.
    Malagari K; Pomoni M; Moschouris H; Kelekis A; Charokopakis A; Bouma E; Spyridopoulos T; Chatziioannou A; Sotirchos V; Karampelas T; Tamvakopoulos C; Filippiadis D; Karagiannis E; Marinis A; Koskinas J; Kelekis DA
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):165-75. PubMed ID: 24263774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation and biological characteristics of a new doxorubicin-gelatin-microspheres for hepatic artery embolization].
    Wan Y; Ma Y; Chen XL; Duan LG; Luo DH; Xia CQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):119-24. PubMed ID: 21355316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms.
    Hashimoto N; Kawai S; Mikuriya S; Oda T; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Yumoto Y; Makino M
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S21-5. PubMed ID: 2466582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization with gelatin sponge microparticles for barcelona clinic liver cancer Stage C and large hepatocellular carcinoma: Initial clinical experience.
    Zhou J; Liu Y; Ren Z; Zhang Y; Zhang M
    J Cancer Res Ther; 2017; 13(5):767-772. PubMed ID: 29237901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal.
    Kong D; Jiang T; Liu J; Jiang X; Liu B; Lou C; Zhao B; Carroll SL; Feng G
    Drug Deliv; 2020 Nov; 27(1):1729-1740. PubMed ID: 33307843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embolization therapy with microspheres for the treatment of liver cancer: State-of-the-art of clinical translation.
    Pérez-López A; Martín-Sabroso C; Gómez-Lázaro L; Torres-Suárez AI; Aparicio-Blanco J
    Acta Biomater; 2022 Sep; 149():1-15. PubMed ID: 35842035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoembolization of liver cancer with drug-loading microsphere 50-100μm.
    Sun JH; Zhou GH; Zhang YL; Nie CH; Zhou TY; Ai J; Zhu TY; Wang WL; Zheng SS
    Oncotarget; 2017 Jan; 8(3):5392-5399. PubMed ID: 28036272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
    Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
    AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.
    Liu B; Huang JW; Li Y; Hu BS; He X; Zhao W; Zheng YB; Lu LG
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1103-8. PubMed ID: 25504506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
    Brown KT; Do RK; Gonen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson KN; Garcia AR; Beattie C; Zhao B; Solomon SB; Schwartz LH; DeMatteo R; Abou-Alfa GK
    J Clin Oncol; 2016 Jun; 34(17):2046-53. PubMed ID: 26834067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates.
    Takayasu K; Muramatsu Y; Maeda T; Iwata R; Furukawa H; Muramatsu Y; Moriyama N; Okusaka T; Okada S; Ueno H
    AJR Am J Roentgenol; 2001 Mar; 176(3):681-8. PubMed ID: 11222205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.
    Carr BI; Kondragunta V; Buch SC; Branch RA
    Cancer; 2010 Mar; 116(5):1305-14. PubMed ID: 20066715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.